52
Views
4
CrossRef citations to date
0
Altmetric
Review

Agents for attention-deficit hyperactivity disorder – an update

Pages 983-1008 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Antonio Molina-Carballo, Ana Checa-Ros & Antonio Muñoz-Hoyos. (2016) Treatments and compositions for attention deficit hyperactivity disorder: a patent review. Expert Opinion on Therapeutic Patents 26:7, pages 799-814.
Read now
Michael Berlin & Christopher W Boyce. (2007) Recent advances in the development of histamine H3 antagonists. Expert Opinion on Therapeutic Patents 17:6, pages 675-687.
Read now

Articles from other publishers (2)

Sylvain Celanire, Maikel Wijtmans, Patrice Talaga, Rob Leurs & Iwan J.P. de Esch. (2005) Keynote review: Histamine H3 receptor antagonists reach out for the clinic. Drug Discovery Today 10:23-24, pages 1613-1627.
Crossref
Rob Leurs, Remko A. Bakker, Henk Timmerman & Iwan J. P. de Esch. (2005) The histamine H3 receptor: from gene cloning to H3 receptor drugs. Nature Reviews Drug Discovery 4:2, pages 107-120.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.